raloxifene hydrochloride

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 82640-04-8

Where It Comes From

31 FDA-registered drug labelers
A-S Medication Solutions
AARTI DRUGS LTD
Alivus Life Sciences Limited
American Health Packaging
Amneal Pharmaceuticals LLC
Aphena Pharma Solutions - Tennessee, LLC
Aurobindo Pharma Limited
AvPAK
Bryant Ranch Prepack
Cadila Pharmaceuticals Limited
Cambrex Profarmaco Milano Srl
Cipla USA Inc.
Dr.Reddys Laboratories Inc
Dr.Reddys Laboratories Limited
Eli Lilly and Company
Eli Lilly Kinsale Limited
Erregierre SpA
Exelan Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Inc., USA
Glochem Industries Private Limited
Hetero Drugs Limited
Lilly del Caribe, Inc.
Lilly S.A.
Major Pharmaceuticals
Modavar Pharmaceuticals LLC
NorthStar Rx LLC
Olon S.p.A.
ScieGen Pharmaceuticals Inc
Sicor S.r.l.
Srini Pharmaceuticals Private Limited
Teva Pharmaceuticals USA, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 2 drug and cosmetic product listings (FDA).

  • Raloxifene hydrochloride
  • Evista
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS82640-04-8
PubChem CID54900
DTXSIDDTXSID1034181
FormulaC28H28ClNO4S
Mol. Weight510 g/mol
SMILESC1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl

Data Sources

549002026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/raloxifene hydrochloride/cids/JSON

Archive: data/sources/pubchem_name/raloxifene hydrochloride.json

CAS 82640-04-82026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json